Dual-Targeting Biomimetic Nanomaterials for Photo-/Chemo-/Antiangiogenic Synergistic Therapy.

Avoiding the low specificity of phototheranostic reagents at the tumor site is a major challenge in cancer phototherapy. Meanwhile, angiogenesis in the tumor is not only the premise of tumor occurrence but also the basis of tumor growth, invasion, and metastasis, making it an ideal strategy for tumor therapy. Herein, biomimetic cancer cell membrane-coated nanodrugs (mBPP NPs) have been prepared by integrating (i) homotypic cancer cell membranes for evading immune cell phagocytosis to increase drug accumulation, (ii) protocatechuic acid for tumor vascular targeting along with chemotherapy effect, and (iii) near-infrared phototherapeutic agent diketopyrrolopyrrole derivative for photodynamic/photothermal synergetic therapy. The mBPP NPs exhibit high biocompatibility, superb phototoxicity, excellent antiangiogenic ability, and double-trigging cancer cell apoptosis in vitro. More significantly, mBPP NPs could specifically bind to tumor cells and vasculature after intravenous injection, inducing fluorescence and photothermal imaging-guided tumor ablation without recurrence and side effects in vivo. The biomimetic mBPP NPs could cause drug accumulation at the tumor site, inhibit tumor neovascularization, and improve phototherapy efficiency, providing a novel avenue for cancer treatment.

[1]  Wei Huang,et al.  Photo‐facilitated chemodynamic therapeutic agents: Synthesis, mechanisms, and biomedical applications , 2023, BMEMat.

[2]  Yulan Liu,et al.  Protocatechuic acid and quercetin attenuate ETEC-caused IPEC-1 cell inflammation and injury associated with inhibition of necroptosis and pyroptosis signaling pathways , 2023, Journal of Animal Science and Biotechnology.

[3]  Samedy Ouk,et al.  Targeted Lymphoma Therapy Using a Gold Nanoframework-Based Drug Delivery System. , 2023, ACS applied materials & interfaces.

[4]  T. Beißbarth,et al.  Molecular differences of angiogenic versus vessel co-opting colorectal cancer liver metastases at single-cell resolution , 2023, Molecular Cancer.

[5]  Changping Ruan,et al.  Copper-Nitrogen-Coordinated Carbon Dots: Transformable Phototheranostics from Precise PTT/PDT to Post-Treatment Imaging-Guided PDT for Residual Tumor Cells. , 2023, ACS applied materials & interfaces.

[6]  C. Li,et al.  Chirality-Dependent Tumor Phototherapy Using Amino Acid-Engineered Chiral Phosphorene. , 2023, ACS applied materials & interfaces.

[7]  Jiajia Hu,et al.  Tumor microenvironment targeting system for glioma treatment via fusion cell membrane coating nanotechnology. , 2023, Biomaterials.

[8]  Li Wang,et al.  Nanomedicines with high drug availability and drug sensitivity overcome hypoxia-associated drug resistance. , 2023, Biomaterials.

[9]  Jianguo Wang,et al.  Acceptor Planarization and Donor Rotation: A Facile Strategy for Realizing Synergistic Cancer Phototherapy via Type I PDT and PTT. , 2022, ACS nano.

[10]  I. Naletova,et al.  Protocatechuic Acid, a Simple Plant Secondary Metabolite, Induced Apoptosis by Promoting Oxidative Stress through HO-1 Downregulation and p21 Upregulation in Colon Cancer Cells , 2021, Biomolecules.

[11]  E. Tasciotti,et al.  Cell membrane coating integrity affects the internalization mechanism of biomimetic nanoparticles , 2021, Nature Communications.

[12]  Wei Wang,et al.  Biomimetic nanoparticles loading with gamabutolin-indomethacin for chemo/photothermal therapy of cervical cancer and anti-inflammation. , 2021, Journal of controlled release : official journal of the Controlled Release Society.

[13]  M. Bruchez,et al.  Monotherapy and Combination Therapy Using Anti‐Angiogenic Nanoagents to Fight Cancer , 2021, Advanced materials.

[14]  W. Duan,et al.  Tumor cell membrane-based peptide delivery system targeting the tumor microenvironment for cancer immunotherapy and diagnosis. , 2020, Acta biomaterialia.

[15]  Y. Xing,et al.  Cancer Cell Membrane Camouflaged Semi-Yolk@Spiky-Shell Nanomotor for Enhanced Cell Adhesion and Synergistic Therapy. , 2020, Small.

[16]  Li Han,et al.  New progress in the pharmacology of protocatechuic acid: A compound ingested in daily foods and herbs frequently and heavily. , 2020, Pharmacological research.

[17]  B. Tang,et al.  An All‐Round Athlete on the Track of Phototheranostics: Subtly Regulating the Balance between Radiative and Nonradiative Decays for Multimodal Imaging‐Guided Synergistic Therapy , 2020, Advanced materials.

[18]  Qiuhong Liu,et al.  A pH‐Sensitive Self‐Assembled and Carrier‐Free Nanoparticle Based on Charge Reversal for Enhanced Synergetic Chemo‐Phototherapy , 2020, Advanced healthcare materials.

[19]  B. Grzybowski,et al.  Targeted crystallization of mixed-charge nanoparticles in lysosomes induces selective death of cancer cells , 2020, Nature Nanotechnology.

[20]  Younan Xia,et al.  Killing cancer cells by rupturing their lysosomes , 2020, Nature Nanotechnology.

[21]  Chunxi Wang,et al.  Cell Membrane-Camouflaged Nanocarriers for Cancer Diagnostic and Therapeutic , 2020, Frontiers in Pharmacology.

[22]  C. Oxvig,et al.  Differential Nanoparticle Sequestration by Macrophages and Scavenger Endothelial Cells Visualized In Vivo in Real-Time and at Ultrastructural Resolution. , 2020, ACS nano.

[23]  J. L. Paris,et al.  Nanoparticles for Multimodal Antivascular Therapeutics: Dual Drug Release, Photothermal and Photodynamic Therapy. , 2019, Acta biomaterialia.

[24]  A. Dimberg,et al.  Tumor angiogenesis: causes, consequences, challenges and opportunities , 2019, Cellular and Molecular Life Sciences.

[25]  Y. Luan,et al.  Low side-effect and heat-shock protein-inhibited chemo-phototherapy nanoplatform via co-assembling strategy of biotin-tailored IR780 and quercetin , 2019 .

[26]  N. Ferrara,et al.  VEGF in Signaling and Disease: Beyond Discovery and Development , 2019, Cell.

[27]  F. Qu,et al.  Hollow CuS nanocube as nanocarrier for synergetic chemo/photothermal/photodynamic therapy. , 2019, Materials science & engineering. C, Materials for biological applications.

[28]  D. Oupický,et al.  Near-infrared light-activated IR780-loaded liposomes for anti-tumor angiogenesis and Photothermal therapy. , 2018, Nanomedicine : nanotechnology, biology, and medicine.

[29]  Ziyan Guo,et al.  Protocatechuic acid inhibits the growth of ovarian cancer cells by inducing apoptosis and autophagy , 2018, Phytotherapy research : PTR.

[30]  P. Cheung,et al.  Mechanistic Study of the In Vitro and In Vivo Inhibitory Effects of Protocatechuic Acid and Syringic Acid on VEGF-Induced Angiogenesis. , 2018, Journal of agricultural and food chemistry.

[31]  Hui-zhen Jia,et al.  NIR-responsive cancer cytomembrane-cloaked carrier-free nanosystems for highly efficient and self-targeted tumor drug delivery. , 2018, Biomaterials.

[32]  Bruno Larrivée,et al.  Tumor angiogenesis and vascular normalization: alternative therapeutic targets , 2017, Angiogenesis.

[33]  Xiaoyuan Chen,et al.  Rethinking cancer nanotheranostics. , 2017, Nature reviews. Materials.

[34]  P. Kantoff,et al.  Cancer nanomedicine: progress, challenges and opportunities , 2016, Nature Reviews Cancer.

[35]  Ping Gong,et al.  Cancer Cell Membrane-Biomimetic Nanoparticles for Homologous-Targeting Dual-Modal Imaging and Photothermal Therapy. , 2016, ACS nano.

[36]  Mauro Ferrari,et al.  Principles of nanoparticle design for overcoming biological barriers to drug delivery , 2015, Nature Biotechnology.

[37]  S. McKeown,et al.  Defining normoxia, physoxia and hypoxia in tumours-implications for treatment response. , 2014, The British journal of radiology.

[38]  Younan Xia,et al.  A plasmon-assisted optofluidic (PAOF) system for measuring the photothermal conversion efficiencies of gold nanostructures and controlling an electrical switch. , 2013, Angewandte Chemie.

[39]  Hsi-Chin Wu,et al.  Apoptotic effects of protocatechuic acid in human breast, lung, liver, cervix, and prostate cancer cells: potential mechanisms of action. , 2009, Journal of agricultural and food chemistry.